chr14-20197832-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001386033.1(OR11G2):c.395G>A(p.Arg132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000812 in 1,613,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R132W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001386033.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR11G2 | NM_001386033.1 | c.395G>A | p.Arg132Gln | missense_variant | 2/2 | ENST00000641879.2 | |
OR11G2 | NM_001005503.2 | c.395G>A | p.Arg132Gln | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR11G2 | ENST00000641879.2 | c.395G>A | p.Arg132Gln | missense_variant | 2/2 | NM_001386033.1 | P1 | ||
OR11G2 | ENST00000641682.1 | c.395G>A | p.Arg132Gln | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151882Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251474Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135910
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461868Hom.: 0 Cov.: 44 AF XY: 0.0000784 AC XY: 57AN XY: 727234
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151882Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74172
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 27, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at